While the advisory will tell recipients to watch out for certain symptoms for at least 28 days after taking the shot, experts say blood clo...

The findings are based on 280,000 people aged 18-65 who received a first dose of the Oxford-AstraZeneca vaccine.

CDC Director Dr. Rochelle Walensky added that the pause should increase confidence in vaccine safety, showing "that we are taking every one...

The agency said there were "no or limited data to change current recommendations." It said it wasn't known whether the risk of a rare blood...

Earlier this month, the Amsterdam-based drug regulator for the 27-nation European Union said there was a "possible link" between the AstraZ...

Nearly a million people have been given the first dose of the Indian-made vaccine in the country. No announcement of any halt to the vaccin...

The risk is extremely low, and the link between blood clots and the Oxford-AstraZeneca vaccine is still not 100% clear. Also, the clots can...

AstraZeneca, which had been buffeted by similar blood-clotting concerns for weeks, agreed, while Pfizer Inc and Moderna executive declined,...

A study of 500,000 COVID-19 patients found CVST had occurred at a rate of 39 people out of a million following infection, researchers said....

Concerning symptoms may occur a week to three weeks after the J&J vaccine.

With both the AstraZeneca and Johnson & Johnson (J&J)vaccines, the reports involve extremely rare clotting, including a type of blood clot ...

In a joint statement Tuesday, the Centers for Disease Control and Prevention and the Food and Drug Administration said they were investigat...

WHO said there is an acute shortage of vaccines and most countries did not have any doses to cover frontline workers such as healthcare sta...

The EMA said its vaccine side effects monitoring system, as of April 4, had received 169 reports of cases of cerebral venous sinus thrombos...

MHRA, European Medicines Agency and the World Health Organization have reiterated that benefits of the vaccine in the prevention of COVID-1...

Earlier in March, more than a dozen countries, including Germany, suspended their use of AstraZeneca over the blood clot issue.

A growing number of European countries - including Germany, France, Italy and Spain - suspended use of the AstraZeneca vaccine on Monday, t...